HepaHope —We Deliver A Better Life

HepaHope develops and commercializes therapeutic and diagnostic technologies to improve patient health.

We strive to improve the quality of life and life expectancy of liver failure patients with our Bio-Artificial Liver device.
We aim to create a new paradigm shift in diagnostics.

HepaHope News

  • 3.22.12 – On March 15, 2012, the U. S. Food and Drug Administration (FDA) notified HepaHope that the clinical hold of HepaHope's Hepapherisis™ therapy to treat human subjects in a proposed Phase I/IIa clinical trial was removed.read full announcement.
  • 2.24.11 - The City of Hope Medical Research Center has signed an agreement to provide HepaHope with a variety of malignant human tumor tissue samples in a joint project to evaluate the potential of HepaHope's Chemosensitivity Testing device for use in personalized medicine.